← Back to Patent Explorer
US6521179B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Sterilization

Assignee: Biomedical Design Inc
•
Filing: 2000-08-09
•
Granted: 2003-02-18
•
Expires: 2020-08-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Allograft tissue prostheses, as well as tissue valves for replacement of defective heart valves and other tissue-engineered products (TEPs), are effectively sterilized by treatment with a coupling agent known to create amide linkages between amines and carboxylic acids in the presence of a protecting agent. The sterilization treatment preferably employs EDC as a water-soluble coupling agent, plus a water-soluble protecting agent which complexes with potentially reactive amine or carboxyl moieties on the biological tissue, in the optional presence of isopropanol or an equivalent alkanol. One preferred sterilization treatment process uses a buffered aqueous solution where a hydroxymonoamine buffer, such as TRIS plus ethanolamine, provides both the buffering effect and the protecting agents, effectively complexing with potentially reactive carboxyl moieties on the tissue. The treatment is particularly advantageous for sterilizing fresh biological tissue where substantial cross-linking that would alter physical properties of the tissue is undesirable or any tissues or TEPs where a controllable amount of cross-linking is desired.

Inventors

  • 👤 Jean-Marie Girardot
  • 👤 Marie-Nadia Girardot

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:50
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3683; A61L27/3687; A01; A01N; A01N1/00; A61L2/00; A61L2/16; A61L2/18; A61L27/3691; A61L2103/00; A61L2103/05; Y; Y10; Y10S; Y10S623/00; Y10S623/915; Y10S623/92

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 120 words
A process for sterilization of biological tissue material, which process comprises treating such material with an aqueous solution containing (a) an amount of a water-soluble coupling agent capable of creating amide bonds that is effective to achieve sterilization and (b) an amount of a protecting agent which is effective to complex with potentially reactive amine or carboxyl moieties on the biological tissue material so as to deter such complexed moieties from taking part in an amide-forming cross-linking reaction and thereby limit the amount of cross-linking, and maintaining such treatment for a time and at a temperature which is sufficient to achieve penetration of said coupling agent into the cells of microorganisms carried by such material and effectively kill such microorganisms.
Claim 2
Dependent Claim 120 words
A process for sterilization of biological tissue material, which process comprises treating such material with an aqueous solution containing (a) an amount of a water-soluble coupling agent capable of creating amide bonds that is effective to achieve sterilization and (b) an amount of a protecting agent which is effective to complex with potentially reactive amine or carboxyl moieties on the biological tissue material so as to deter such complexed moieties from taking part in an amide-forming cross-linking reaction and thereby limit the amount of cross-linking, and maintaining such treatment for a time and at a temperature which is sufficient to achieve penetration of said coupling agent into the cells of microorganisms carried by such material and effectively kill such microorganisms.
Claim 3
Dependent Claim 26 words
The process for sterilization according to claim 1 wherein said coupling agent is present in said solution at a concentration of at least about 25 mM.
Claim 4
Dependent Claim 35 words
The process for sterilization according to claim 2 wherein said treatment is carried out at a temperature of about 25° to about 55° C. in the presence of an effective amount of a lower alkanol.
Claim 5
Dependent Claim 46 words
The process for sterilization according to claim 2 wherein said treatment is carried out at a temperature of at least about 35° C. in the absence of any effective amount of a lower alkanol and said treatment is carried out for at least about 24 hours.
Claim 6
Dependent Claim 27 words
The process for sterilization according to claim 2 wherein said protecting agent is present in said aqueous solution at a concentration of at least about 25 mM.
Claim 7
Dependent Claim 15 words
The process for sterilization according to claim 5 wherein said protecting agent includes a monoamine.
Claim 8
Dependent Claim 16 words
The process for sterilization according to claim 5 wherein said protecting agent includes a monocarboxylic acid.
Claim 9
Dependent Claim 42 words
The process for sterilization according to claim 1 wherein said coupling agent is present in said solution at a concentration of at least about 35 mM and said protecting agent is present at a concentration between about 50 and about 150 mM.
Claim 10
Dependent Claim 20 words
The process for sterilization according to claim 8 wherein said treatment is carried out for at least about 6 hours.
Claim 11
Dependent Claim 47 words
The process for sterilization according to claim 1 wherein said coupling agent is EDC which is present at a concentration of at least about 50 millimolar and said treatment is carried out for at least about 10 hours at a temperature of at least about 40° C.
Claim 12
Dependent Claim 112 words
A process for sterilization of biological tissue, which process comprises treating such biological tissue at a temperature of at least about 35° C. with an aqueous solution containing an effective amount of a lower alkanol and a concentration of at least about 25 mM of a water-soluble coupling agent that is capable of creating amide bonds and maintaining said treatment, in the presence of an effective amount of a protecting agent which complexes with either amine or carboxyl moieties and thereby deters cross-linking, for a period so as to effectively kill any bacteria and spores carried by such biological tissue, whereby contemporaneous cross-linking of the biological material can be controlled as desired.
Claim 13
Dependent Claim 112 words
A process for sterilization of biological tissue, which process comprises treating such biological tissue at a temperature of at least about 35° C. with an aqueous solution containing an effective amount of a lower alkanol and a concentration of at least about 25 mM of a water-soluble coupling agent that is capable of creating amide bonds and maintaining said treatment, in the presence of an effective amount of a protecting agent which complexes with either amine or carboxyl moieties and thereby deters cross-linking, for a period so as to effectively kill any bacteria and spores carried by such biological tissue, whereby contemporaneous cross-linking of the biological material can be controlled as desired.
Claim 14
Dependent Claim 27 words
The process for sterilization according to claim 11 wherein said aqueous solution contains said protecting agent at a concentration of between about 50 and about 150 mM.
Claim 15
Dependent Claim 20 words
The process for sterilization according to claim 11 wherein said protecting agent includes either a monoamine or a monocarboxylic acid.
Claim 16
Dependent Claim 59 words
The process for sterilization according to claim 11 wherein said solution contains EDC as said water-soluble coupling agent at a concentration of at least about 35 mM, wherein said treatment is carried out at between 40° C. and about 50° C. and wherein said treatment is carried out in the presence of at least about 50 mM of ethanolamine.
Claim 17
Dependent Claim 20 words
The process for sterilization according to claim 14 wherein said solution also contains at least about 50 mM of TRIS.
Claim 18
Dependent Claim 115 words
A process for sterilization of biological tissue material, which process comprises treating such material with a protecting agent which is effective to complex with potentially reactive amine or carboxyl moieties on the biological tissue material so as to deter such complexed moieties from taking part in an amide-forming cross-linking reaction and thereby limit the amount of cross-linking, treating such material with a water-soluble coupling agent capable of creating amide bonds that is effective to achieve sterilization, and maintaining such treatment with said coupling agent for a time and at a temperature which is sufficient to achieve penetration of said coupling agent into the cells of microorganisms carried by such material and effectively kill such microorganisms.
Claim 19
Dependent Claim 115 words
A process for sterilization of biological tissue material, which process comprises treating such material with a protecting agent which is effective to complex with potentially reactive amine or carboxyl moieties on the biological tissue material so as to deter such complexed moieties from taking part in an amide-forming cross-linking reaction and thereby limit the amount of cross-linking, treating such material with a water-soluble coupling agent capable of creating amide bonds that is effective to achieve sterilization, and maintaining such treatment with said coupling agent for a time and at a temperature which is sufficient to achieve penetration of said coupling agent into the cells of microorganisms carried by such material and effectively kill such microorganisms.
Claim 20
Dependent Claim 27 words
The process for sterilization according to claim 16 wherein said coupling agent and said protecting agent are present in an aqueous solution being used for said treatment.
Claim 21
Dependent Claim 19 words
The process for sterilization according to claim 17 wherein said protecting agent includes hydroxyproline, lactic acid or acetic acid.
Claim 22
Dependent Claim 41 words
The process for sterilization according to claim 17 wherein said biological tissue material is pretreated with said protecting agent at a concentration of at least about 10 mM and then rinsed before treatment with an aqueous solution of said coupling agent.
Claim 23
Dependent Claim 22 words
The process for sterilization according to claim 19 wherein said protecting agent is sulfo-NHS acetate, acetic anhydride, maleic anhydride or citraconic anhydride.

References Cited (Backward Citations)

US4776853A Cited
US5447536A Cited
US5733339A Cited
WO1997027885A1 Cited
US5911951A Cited
EP0897942A1 Cited
US6117979A Cited
US6166184A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2006-02-17 2006-08-19 2007-02-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2010-02-17 2010-08-19 2011-02-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2014-02-17 2014-08-19 2015-02-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag